Lars Fruergaard Jorgensen

Lars Fruergaard Jorgensen

CEO Denmark

Lars Fruergaard Jorgensen is the CEO of Novo Nordisk, a Danish pharmaceutical company renowned for its innovative treatments for diabetes and obesity. Under his leadership, the company has focused on expanding its portfolio of obesity medications, including the highly successful Wegovy. Jorgensen has emphasized the strong demand for obesity treatments, despite market fluctuations and competition from other pharmaceutical companies.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
59,841
Power
2,892$
Sentiment
4.73
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Denmark 4 5.25 0.27% +0% 5,792,202 15,498 $350,000 936$
Norway 2 4.50 0.16% +0% 5,421,241 8,524 $403,000 634$
United Kingdom 1 5.00 0.04% +0% 67,886,011 23,878 $2,700,000 950$
Sweden 1 4.00 0.06% +0% 10,099,265 5,821 $530,000 305$
Slovakia 1 3.00 0.06% +0% 5,459,642 3,172 $110,000 64$
Ireland 1 4.00 0.06% +0% 5,030,000 2,948 $5,100 3$
Totals 10 99,688,361 59,841 $4,098,100 2,892$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Switzerland Switzerland: Lars Fruergaard Jörgensen led Novo Nordisk to success but was unexpectedly dismissed in May. 5

Neue Zürcher Zeitung: Vom Aufstieg mit Ozempic zum Börsenabsturz

Italy Italy: Lars Fruergaard Jorgensen will leave his position as CEO of Novo Nordisk after the company's stock fell over 50% in the last 12 months. 4

Corriere della Sera: Novo Nordisk, il ceo si dimette dopo il crollo in Borsa: -50% in 12 mesi (due anni fa era la regina d’Europa)

United States United States: Lars Fruergaard Jorgensen is stepping down as CEO of Novo Nordisk due to recent market challenges. 5

CNN: Lars Fruergaard Jorgensen, CEO of Novo Nordisk, which makes Wegovy, is stepping down

Switzerland Switzerland: Lars Fruergaard Jörgensen was the CEO of Novo Nordisk and is stepping down after eight years due to market challenges. 5

Neue Zürcher Zeitung: CEO der Pharmagruppe Novo Nordisk tritt zurück

Canada Canada: Novo Nordisk CEO Lars Fruergaard Jorgensen said on a call with journalists that growth is expected to pick up in the second-half of the year. 6

The Globe and Mail: Market movers: Stocks that saw action on Wednesday - and why

Slovenia Slovenia: Lars Fruergaard Jorgensen is the CEO of Novo who mentioned that his company would feel the short-term effects of tariffs. 5

Delo – major Slovenian daily, est. 1959: Bodo carine zvišale cene zdravil ali pa se bodo farmacevti iz EU preselili v ZDA